메뉴 건너뛰기




Volumn 71, Issue 6, 2012, Pages 935-942

Sodium oxybate therapy provides multidimensional improvement in fi bromyalgia: Results of an international phase 3 trial

Author keywords

[No Author keywords available]

Indexed keywords

OXYBATE SODIUM; PLACEBO;

EID: 84862821324     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200418     Document Type: Article
Times cited : (45)

References (45)
  • 2
    • 43649085186 scopus 로고    scopus 로고
    • Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice
    • DOI 10.1016/j.sleep.2007.07.007, PII S1389945707002638
    • Okura K, Lavigne GJ, Huynh N, et al. Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice. Sleep Med 2008;9:352-61. (Pubitemid 351681421)
    • (2008) Sleep Medicine , vol.9 , Issue.4 , pp. 352-361
    • Okura, K.1    Lavigne, G.J.2    Huynh, N.3    Manzini, C.4    Fillipini, D.5    Montplaisir, J.Y.6
  • 3
    • 33748105797 scopus 로고    scopus 로고
    • Sleep deprivation and pain perception
    • DOI 10.1016/j.smrv.2005.08.001, PII S1087079205000754
    • Lautenbacher S, Kundermann B, Krieg JC. Sleep deprivation and pain perception. Sleep Med Rev 2006;10:357-69. (Pubitemid 44307712)
    • (2006) Sleep Medicine Reviews , vol.10 , Issue.5 , pp. 357-369
    • Lautenbacher, S.1    Kundermann, B.2    Krieg, J.-C.3
  • 4
    • 9244236543 scopus 로고    scopus 로고
    • Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers
    • DOI 10.1097/01.psy.0000145912.24553.c0
    • Kundermann B, Spernal J, Huber MT, et al. Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-7. (Pubitemid 39552878)
    • (2004) Psychosomatic Medicine , vol.66 , Issue.6 , pp. 932-937
    • Kundermann, B.1    Spernal, J.2    Huber, M.T.3    Krieg, J.-C.4    Lautenbacher, S.5
  • 5
    • 33646923473 scopus 로고    scopus 로고
    • Sleep loss and REM sleep loss are hyperalgesic
    • Roehrs T, Hyde M, Blaisdell B, et al. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006;29:145-51. (Pubitemid 44019967)
    • (2006) Sleep , vol.29 , Issue.2 , pp. 145-151
    • Roehrs, T.1    Hyde, M.2    Blaisdell, B.3    Greenwald, M.4    Roth, T.5
  • 6
    • 73649086947 scopus 로고    scopus 로고
    • Rheumatic manifestations of sleep disorders
    • Moldofsky H. Rheumatic manifestations of sleep disorders. Curr Opin Rheumatol 2010;22:59-63.
    • (2010) Curr Opin Rheumatol , vol.22 , pp. 59-63
    • Moldofsky, H.1
  • 8
    • 38049152731 scopus 로고    scopus 로고
    • Employees with fi bromyalgia: Medical comorbidity, healthcare costs, and work loss
    • White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fi bromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008;50:13-24.
    • (2008) J Occup Environ Med , vol.50 , pp. 13-24
    • White, L.A.1    Birnbaum, H.G.2    Kaltenboeck, A.3
  • 9
    • 77953120247 scopus 로고    scopus 로고
    • Prevalence of fi bromyalgia: A survey in fi ve European countries
    • Branco JC, Bannwarth B, Failde I, et al. Prevalence of fi bromyalgia: a survey in fi ve European countries. Semin Arthritis Rheum 2010;39:448-53.
    • (2010) Semin Arthritis Rheum , vol.39 , pp. 448-453
    • Branco, J.C.1    Bannwarth, B.2    Failde, I.3
  • 10
    • 70450177636 scopus 로고    scopus 로고
    • Fibromyalgia syndrome module at OMERACT 9: Domain construct
    • OMERACT Fibromyalgia Working Group
    • Mease P, Arnold LM, Choy EH, et al.; OMERACT Fibromyalgia Working Group. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009;36:2318-29.
    • (2009) J Rheumatol , vol.36 , pp. 2318-2329
    • Mease, P.1    Arnold, L.M.2    Choy, E.H.3
  • 11
    • 67651202661 scopus 로고    scopus 로고
    • The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fi bromyalgia syndrome
    • Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fi bromyalgia syndrome. Rheum Dis Clin North Am 2009;35:275-83.
    • (2009) Rheum Dis Clin North Am , vol.35 , pp. 275-283
    • Moldofsky, H.1
  • 12
    • 0016594402 scopus 로고
    • Musculosketal symptoms and non-REM sleep disturbance in patients with "fi brositis syndrome" and healthy subjects
    • Moldofsky H, Scarisbrick P, England R, et al. Musculosketal symptoms and non-REM sleep disturbance in patients with "fi brositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
    • (1975) Psychosom Med , vol.37 , pp. 341-351
    • Moldofsky, H.1    Scarisbrick, P.2    England, R.3
  • 13
    • 56649086860 scopus 로고    scopus 로고
    • Restorative sleep predicts the resolution of chronic widespread pain: Results from the EPIFUND study
    • Davies KA, Macfarlane GJ, Nicholl BI, et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford) 2008;47:1809-13.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 1809-1813
    • Davies, K.A.1    Macfarlane, G.J.2    Nicholl, B.I.3
  • 14
    • 33845479670 scopus 로고    scopus 로고
    • Gamma-Hydroxybutyrate/sodium oxybate: Neurobiology, and impact on sleep and wakefulness
    • DOI 10.2165/00023210-200620120-00004
    • Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 2006;20:993-1018. (Pubitemid 44912708)
    • (2006) CNS Drugs , vol.20 , Issue.12 , pp. 993-1018
    • Pardi, D.1    Black, J.2
  • 15
    • 0031752568 scopus 로고    scopus 로고
    • Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report
    • Scharf MB, Hauck M, Stover R, et al. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fi bromyalgia. Preliminary report. J Rheumatol 1998;25:1986-90. (Pubitemid 28459315)
    • (1998) Journal of Rheumatology , vol.25 , Issue.10 , pp. 1986-1990
    • Scharf, M.B.1    Hauck, M.2    Stover, R.3    Mcdannold, M.4    Berkowitz, D.5
  • 16
    • 0038752729 scopus 로고    scopus 로고
    • The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia
    • Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fi bromyalgia. J Rheumatol 2003;30:1070-4. (Pubitemid 36529633)
    • (2003) Journal of Rheumatology , vol.30 , Issue.5 , pp. 1070-1074
    • Scharf, M.B.1    Baumann, M.2    Berkowitz, D.V.3
  • 17
    • 58249095947 scopus 로고    scopus 로고
    • Sodium oxybate relieves pain and improves function in fi bromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial
    • Oxybate SXB-26 Fibromyalgia Syndrome Study Group
    • Russell IJ, Perkins AT, Michalek JE; Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fi bromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009;60:299-309.
    • (2009) Arthritis Rheum , vol.60 , pp. 299-309
    • Russell, I.J.1    Perkins, A.T.2    Michalek, J.E.3
  • 18
    • 77957870727 scopus 로고    scopus 로고
    • Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fi bromyalgia syndrome: A double-blind, randomized, placebo-controlled study
    • Moldofsky H, Inhaber NH, Guinta DR, et al. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fi bromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol 2010;37:2156-66.
    • (2010) J Rheumatol , vol.37 , pp. 2156-2166
    • Moldofsky, H.1    Inhaber, N.H.2    Guinta, D.R.3
  • 19
    • 79954596913 scopus 로고    scopus 로고
    • Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fi bromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study
    • Sodium Oxybate 06-008 FM Study Group
    • Russell IJ, Holman AJ, Swick TJ, et al.; Sodium Oxybate 06-008 FM Study Group. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fi bromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011;152:1007-17.
    • (2011) Pain , vol.152 , pp. 1007-1017
    • Russell, I.J.1    Holman, A.J.2    Swick, T.J.3
  • 22
    • 0026165648 scopus 로고
    • The fibromyalgia impact questionnaire: Development and validation
    • Burckhardt CS, Clark SR, Bennett RM. The fi bromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33.
    • (1991) J Rheumatol , vol.18 , pp. 728-733
    • Burckhardt, C.S.1    Clark, S.R.2    Bennett, R.M.3
  • 24
    • 79952646210 scopus 로고    scopus 로고
    • Assessing sleep in fi bromyalgia: Investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies
    • Crawford BK, Piault EC, Lai C, et al. Assessing sleep in fi bromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies. Clin Exp Rheumatol 2010;28(6 Suppl 63):S100-9.
    • (2010) Clin Exp Rheumatol , vol.28 , Issue.6 SUPPL. 63
    • Crawford, B.K.1    Piault, E.C.2    Lai, C.3
  • 25
    • 0026877917 scopus 로고
    • The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
    • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
    • (1992) Med Care , vol.30 , pp. 473-483
    • Ware Jr., J.E.1    Sherbourne, C.D.2
  • 26
    • 0025688231 scopus 로고
    • EuroQol - A new facility for the measurement of health-related quality of life
    • The EuroQol group
    • The EuroQol group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
    • (1990) Health Policy , vol.16 , pp. 199-208
  • 28
    • 0031058551 scopus 로고    scopus 로고
    • A standardized Manual Tender Point Survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome
    • Okifuji A, Turk DC, Sinclair JD, et al. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fi bromyalgia syndrome. J Rheumatol 1997;24:377-83. (Pubitemid 27104106)
    • (1997) Journal of Rheumatology , vol.24 , Issue.2 , pp. 377-383
    • Okifuji, A.1    Turk, D.C.2    Sinclair, J.D.3    Starz, T.W.4    Marcus, D.A.5
  • 29
    • 0008946321 scopus 로고
    • ECDEU Assessment Manual for Psychopharmacology
    • revised Rockville, MD: US Department of Health, Education, and Welfare
    • Guy W. ECDEU Assessment Manual for Psychopharmacology (revised). DHEW publication no. (ADM) 76-338. Rockville, MD: US Department of Health, Education, and Welfare 1976.
    • (1976) DHEW Publication No. (ADM) 76-338
    • Guy, W.1
  • 30
    • 64849117499 scopus 로고    scopus 로고
    • The efficacy and safety of milnacipran for treatment of fi bromyalgia. A randomized, double-blind, placebo-controlled trial
    • Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fi bromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398-409.
    • (2009) J Rheumatol , vol.36 , pp. 398-409
    • Mease, P.J.1    Clauw, D.J.2    Gendreau, R.M.3
  • 31
    • 34247646890 scopus 로고    scopus 로고
    • The effects of sleep deprivation on pain inhibition and spontaneous pain in women
    • Smith MT, Edwards RR, McCann UD, et al. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30:494-505. (Pubitemid 46668707)
    • (2007) Sleep , vol.30 , Issue.4 , pp. 494-505
    • Smith, M.T.1    Edwards, R.R.2    McCann, U.D.3    Haythomthwaite, J.A.4
  • 32
    • 14044269308 scopus 로고    scopus 로고
    • Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition
    • DOI 10.1016/j.pain.2004.12.032
    • Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fi bromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295-302. (Pubitemid 40279112)
    • (2005) Pain , vol.114 , Issue.1-2 , pp. 295-302
    • Julien, N.1    Goffaux, P.2    Arsenault, P.3    Marchand, S.4
  • 33
    • 67149107748 scopus 로고    scopus 로고
    • Minimal clinically important difference in the fi bromyalgia impact questionnaire
    • Bennett RM, Bushmakin AG, Cappelleri JC, et al. Minimal clinically important difference in the fi bromyalgia impact questionnaire. J Rheumatol 2009;36:1304-11.
    • (2009) J Rheumatol , vol.36 , pp. 1304-1311
    • Bennett, R.M.1    Bushmakin, A.G.2    Cappelleri, J.C.3
  • 34
    • 0032956065 scopus 로고    scopus 로고
    • Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II
    • DOI 10.2165/00019053-199915020-00003
    • Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-55. (Pubitemid 29093257)
    • (1999) PharmacoEconomics , vol.15 , Issue.2 , pp. 141-155
    • Samsa, G.1    Edelman, D.2    Rothman, M.L.3    Williams, G.R.4    Lipscomb, J.5    Matchar, D.6
  • 35
    • 51349119038 scopus 로고    scopus 로고
    • Duloxetine for painful diabetic neuropathy and fi bromyalgia pain: Systematic review of randomised trials
    • Sultan A, Gaskell H, Derry S, et al. Duloxetine for painful diabetic neuropathy and fi bromyalgia pain: systematic review of randomised trials. BMC Neurol 2008;8:29.
    • (2008) BMC Neurol , vol.8 , pp. 29
    • Sultan, A.1    Gaskell, H.2    Derry, S.3
  • 36
    • 77954160849 scopus 로고    scopus 로고
    • Pregabalin in fi bromyalgia - Responder analysis from individual patient data
    • Straube S, Derry S, Moore RA, et al. Pregabalin in fi bromyalgia - responder analysis from individual patient data. BMC Musculoskelet Disord 2010;11:150.
    • (2010) BMC Musculoskelet Disord , vol.11 , pp. 150
    • Straube, S.1    Derry, S.2    Moore, R.A.3
  • 37
    • 57649234533 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fi bromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
    • Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fi bromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
    • (2008) Clin Ther , vol.30 , pp. 1988-2004
    • Clauw, D.J.1    Mease, P.2    Palmer, R.H.3
  • 38
    • 49649095341 scopus 로고    scopus 로고
    • A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fi bromyalgia
    • Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fi bromyalgia. J Pain 2008;9:792-805.
    • (2008) J Pain , vol.9 , pp. 792-805
    • Arnold, L.M.1    Russell, I.J.2    Diri, E.W.3
  • 39
    • 4444381930 scopus 로고    scopus 로고
    • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    • DOI 10.1002/art.20485
    • Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fi bromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84. (Pubitemid 39209537)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.9 , pp. 2974-2984
    • Arnold, L.M.1    Lu, Y.2    Crofford, L.J.3    Wohlreich, M.4    Detke, M.J.5    Iyengar, S.6    Goldstein, D.J.7
  • 40
    • 28644442626 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    • DOI 10.1016/j.pain.2005.06.031, PII S0304395905004628
    • Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebocontrolled trial of duloxetine in the treatment of women with fi bromyalgia with or without major depressive disorder. Pain 2005;119:5-15. (Pubitemid 41752960)
    • (2005) Pain , vol.119 , Issue.1-3 , pp. 5-15
    • Arnold, L.M.1    Rosen, A.2    Pritchett, Y.L.3    D'Souza, D.N.4    Goldstein, D.J.5    Iyengar, S.6    Wernicke, J.F.7
  • 43
    • 43749108365 scopus 로고    scopus 로고
    • What are the key symptoms of fi bromyalgia? Results of a survey of the German Fibromyalgia Association
    • Häuser W, Zimmer C, Felde E, et al. [What are the key symptoms of fi bromyalgia? Results of a survey of the German Fibromyalgia Association]. Schmerz 2008;22:176-83.
    • (2008) Schmerz , vol.22 , pp. 176-183
    • Häuser, W.1    Zimmer, C.2    Felde, E.3
  • 45
    • 77951735184 scopus 로고    scopus 로고
    • The American College of Rheumatology preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity
    • Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 600-610
    • Wolfe, F.1    Clauw, D.J.2    Fitzcharles, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.